Oxitan (Oxaliplatin)

Oxaliplatin Kabi
5 mg/ml
Concentrate for solution for infusion
 

Details

Oxaliplatin is a platinum-based drug, usually classified as alkylating group.

Oxaliplatin in combination with 5-fluorouracil and folinic acid is indicated for:

  • Adjuvant treatment of stage III (Duke’s C) colon carcinoma after complete resection of primary tumor
  • Treatment of metastatic colorectal carcinoma

Strength is denoted by disposable cap color.

RTU (Ready to use) Concentrate:

  • Oxaliplatin Kabi 50 mg/25ml
  • Oxaliplatin Kabi 100 mg/50 ml

Registered product information may differ in your country. Before prescribing refer to nationally approved Prescribing Information.